Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_assertion type Assertion NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_head.
- NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_assertion description "[However, patients with the MTRR 66 AA/AG genotypes were found to have a significantly worse cancer-specific survival when the mucosa were positive, compared with negative, for p16 hypermethylation (hazard ratio 2.7; 95% confidence interval 1.2-6.4; P = 0.023).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_provenance.
- NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_assertion evidence source_evidence_literature NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_provenance.
- NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_assertion SIO_000772 20549016 NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_provenance.
- NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_assertion wasDerivedFrom befree-20140225 NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_provenance.
- NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_assertion wasGeneratedBy ECO_0000203 NP714758.RAD3MIgc-Q2eHUWT8KJLtaLylzDNJuHt3FMT0CJf06Zos130_provenance.